Identification and characterization of five-transmembrane isoforms of human vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors

被引:29
|
作者
Bokaei, Payman Baradar
Ma, Xue-Zhong
Byczynski, Bartosz
Keller, Jeremy
Sakac, Darinka
Fahim, Soad
Branch, Donald R.
机构
[1] Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 2M1, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada
[3] Canadian Red Cross Blood Transfus Serv, Toronto, ON M5G 2M1, Canada
[4] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada
[5] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada
关键词
vasoactive intestinal peptide receptors; splice variants; five-transmembrane; VIPR1; VPAC1; VIPR2; VPAC2; GPCR;
D O I
10.1016/j.ygeno.2006.07.008
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The seven- transmembrane (7TM) G-protein-coupled neuroendocrine receptors VPAC1 (HGNC approved gene symbol VIPR1) and VPAC2 (HGNC approved gene symbol VIPR2) are expressed in different tissues and involved in the regulation of important biological functions. We now report the identification and characterization of novel five-transmembrane(5TM) forms of both human VPAC1 and human VPAC2. These alternatively spliced variant mRNAs result from the skipping of exons 10/11, spanning the third intracellular loop, the fourth extracellular loop, and the transmembrane regions 6 and 7, producing in-frarne 5TM receptors predicted to lack a G-protein-binding motif. RT-PCR showed that these 5TM receptors are differentially expressed in transformed and normal cells. Translation of the 5TM protein was demonstrated by transfection and expression in CHO cells. Following agonist stimulation, differential signaling of the 7TM versus 5TM forms was shown both for the activation of adenylate cyclase and for tyrosine phosphorylation. The identification of these splice variants in various cells and their expression and differential signal transduction compared to the 7TM form suggest that these novel receptors have biological relevance. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:791 / 800
页数:10
相关论文
共 50 条
  • [1] RECEPTORS FOR PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE - COMPARISON WITH VASOACTIVE-INTESTINAL-PEPTIDE RECEPTORS
    ARIMURA, A
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1992, 3 (08): : 288 - 294
  • [2] Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex
    Zawilska, JB
    Niewiadomski, P
    Nowak, JZ
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2003, 20 (02) : 153 - 161
  • [3] Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex
    Jolanta B. Zawilska
    Pawel Niewiadomski
    Jerzy Z. Nowak
    Journal of Molecular Neuroscience, 2003, 20 : 153 - 161
  • [4] Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex
    Zawilska, JB
    Niewiadomski, P
    Nowak, JZ
    POLISH JOURNAL OF PHARMACOLOGY, 2004, 56 (02): : 203 - 211
  • [5] Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland
    Mazzocchi, G
    Malendowicz, LK
    Rebuffat, P
    Gottardo, L
    Nussdorfer, GG
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06): : 2575 - 2580
  • [6] Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate
    Solano, RM
    Carmena, MJ
    Carrero, I
    Cavallaro, S
    Roman, F
    Hueso, C
    Travali, S
    LopezFraile, N
    Guijarro, LG
    Prieto, JC
    ENDOCRINOLOGY, 1996, 137 (07) : 2815 - 2822
  • [7] Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer
    Moody, Terry W.
    Nuche-Berenguer, Bernardo
    Jensen, Robert T.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2016, 23 (01) : 38 - 47
  • [8] Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors
    Igarashi, H
    Ito, T
    Mantey, SA
    Pradhan, TK
    Hou, W
    Coy, DH
    Jensen, RT
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (01): : 370 - 381
  • [9] The Role of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide in Migraine Pathogenesis
    Sokolov, A. Y.
    Osipchuk, A. V.
    Skiba, I. B.
    Amelin, A. V.
    NEUROCHEMICAL JOURNAL, 2022, 16 (01) : 31 - 38
  • [10] Neuroprotection: A comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
    Brenneman, Douglas E.
    PEPTIDES, 2007, 28 (09) : 1720 - 1726